Literature DB >> 25925486

Evaluation of the single-incision Elevate system to treat pelvic organ prolapse: follow-up from 15 to 45 months.

Kuan-Hui Huang1, Li-Yi Huang, Li-Ching Chu, Fei-Chi Chuang, Ming-Ping Wu, Fu-Tsai Kung.   

Abstract

INTRODUCTION AND HYPOTHESIS: The aim of this study was to assess the 2-year clinical outcomes of pelvic reconstructive surgery with the single-incision Elevate system (American Medical Systems, Minnetonka, MN, USA).
METHODS: This retrospective study was conducted from November 2010 to August 2013, and included 210 patients with pelvic organ prolapse stage 3 or 4 who underwent pelvic reconstructive surgery with an Elevate system and were followed for 1 to 3 years postoperatively. Assessments included pre- and postoperative Pelvic Organ Prolapse Quantification (POP-Q) stage, Urogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire (IIQ-7) and multi-channel urodynamic examinations. Anatomical success was defined as postoperative POP-Q stage 0 or I.
RESULTS: The anatomical success rates were 95 % for the anterior vaginal wall, 99 % for the posterior vaginal wall and 94 % for the apical vaginal wall after a median 27 months of follow-up. POP-Q, UDI-6 and IIQ-7 scores, maximal flow rate and post-voiding residual urine all improved significantly after surgery. Complications included 1 case of internal bleeding, 4 cases of mesh exposure, 5 cases of recurrent prolapse that required salvage operations, and 3 cases of urine retention that required intermittent catheterization. There were no bladder or bowel injuries during surgery.
CONCLUSIONS: Pelvic reconstructive surgery with the Elevate system yielded good anatomical outcomes and symptom improvement after 2 years of follow-up.

Entities:  

Mesh:

Year:  2015        PMID: 25925486     DOI: 10.1007/s00192-015-2693-x

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  18 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Am J Obstet Gynecol       Date:  2002-07       Impact factor: 8.661

3.  Comparison of clinical outcome and urodynamic findings using "Perigee and/or Apogee" versus "Prolift anterior and/or posterior" system devices for the treatment of pelvic organ prolapse.

Authors:  Cheng-Yu Long; Chun-Shuo Hsu; Mei-Yu Jang; Cheng-Min Liu; Po-Hui Chiang; Eing-Mei Tsai
Journal:  Int Urogynecol J       Date:  2010-09-10       Impact factor: 2.894

4.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

5.  Prolapse repair using the Elevate™ kit: prospective study on 70 patients.

Authors:  H Azaïs; C Jean Charles; P Delporte; P Debodinance
Journal:  Int Urogynecol J       Date:  2012-03-01       Impact factor: 2.894

6.  Prospective randomized trial of polyglactin 910 mesh to prevent recurrence of cystoceles and rectoceles.

Authors:  P K Sand; S Koduri; R W Lobel; H A Winkler; J Tomezsko; P J Culligan; R Goldberg
Journal:  Am J Obstet Gynecol       Date:  2001-06       Impact factor: 8.661

7.  The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery.

Authors:  A H MacLennan; A W Taylor; D H Wilson; D Wilson
Journal:  BJOG       Date:  2000-12       Impact factor: 6.531

8.  Single-incision apical and posterior mesh repair: 1-year prospective outcomes.

Authors:  James C Lukban; Jan-Paul W R Roovers; Douglas M Vandrie; Ty Erickson; Samuel Zylstra; Manish P Patel; Robert D Moore
Journal:  Int Urogynecol J       Date:  2012-03-15       Impact factor: 2.894

9.  Use of the Gynecare Prolift system in surgery for pelvic organ prolapse: 1-year outcome.

Authors:  Ganesh Raj Vaiyapuri; How Chuan Han; Lih Charn Lee; Leng Aun Arthur Tseng; Heng Fok Wong
Journal:  Int Urogynecol J       Date:  2011-04-09       Impact factor: 2.894

10.  Elevate anterior/apical: 12-month data showing safety and efficacy in surgical treatment of pelvic organ prolapse.

Authors:  Edward J Stanford; Robert D Moore; Jan-Paul W R Roovers; Christophe Courtieu; James C Lukban; Eduardo Bataller; Bernhard Liedl; Suzette E Sutherland
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 Mar-Apr       Impact factor: 2.091

View more
  2 in total

1.  Evidence to justify retention of transvaginal mesh: comparison between laparoscopic sacral colpopexy and transvaginal Elevate™ mesh.

Authors:  Valérie To; Pattaya Hengrasmee; Alan Lam; Georgina Luscombe; Anna Lawless; Justin Lam
Journal:  Int Urogynecol J       Date:  2017-06-15       Impact factor: 2.894

2.  Efficacy and safety of Elevate® system on apical and anterior compartment prolapse repair with personal technique modification.

Authors:  Daniele Castellani; Vikiela Galica; Pietro Saldutto; Giuseppe Paradiso Galatioto; Carlo Vicentini
Journal:  Int Braz J Urol       Date:  2017 Nov-Dec       Impact factor: 1.541

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.